Mohammed Almubarak

Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma

Steven G. Waguespack, Alexander Drilon, Marcia S. Brose et al. · The Medicine Forum · 2022 · 125 citations · Full text

Medicine, Oncology, Pharmacology +15

Guideline-concordant lung cancer care and associated health outcomes among elderly patients in the United States

Pramit Nadpara, S. Suresh Madhavan, Cindy Tworek et al. · Journal of Geriatric Oncology · 2015 · 74 citations · Full text

Medicine, Geriatric Medicine, Oncology +12

Can Positron Emission Tomography Be Used as a Staging Tool for Small-Cell Lung Cancer?

Mridula Vinjamuri, Michael Craig, Annette Campbell-Fontaine et al. · Clinical Lung Cancer · 2008 · 50 citations

Medicine, Nuclear Medicine, Oncology +14

A Prospective Trial Evaluating the Safety and Systemic Response From the Concurrent Use of Radiation Therapy with Checkpoint Inhibitor Immunotherapy in Metastatic Non–Small Cell Lung Cancer

Malcolm D. Mattes, Timothy D. Eubank, Mohammed Almubarak et al. · Clinical Lung Cancer · 2021 · 42 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Phase 1b/2, open label, multicenter, study of the combination of SD-101 and pembrolizumab in patients with advanced melanoma who are naïve to anti-PD-1 therapy.

Mohammed Milhem, Georgina V. Long, Christopher Hoimes et al. · Journal of Clinical Oncology · 2019 · 33 citations · Full text

Pharmacy, Oncology, Pharmacology +17